Peptide Reference

What a Clean Mass Spectrum Does Not Prove

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

Mass spectrometry compares an observed mass against an expected one, so any impurity with the same molecular formula is invisible to it. That includes isoaspartyl rearrangements, D-amino acid epimers and misfolded disulfide isomers, all real and all identical in mass.

Key facts

What MS establishes
Molecular mass, therefore formula
Invisible: isoaspartate
Bond moved, same atoms
Invisible: D-epimers
Mirror image, same atoms
Invisible: disulfide isomers
Wrong pairing, same atoms
Common to all three
Identical molecular formula
What does detect them
Chromatography, activity, chiral methods

What mass spectrometry is actually doing

Measuring mass-to-charge ratio, from which molecular mass and therefore molecular formula follow. It is an excellent identity check and a poor structural one, because a formula does not specify an arrangement. Any error that rearranges atoms without adding or removing them produces an identical spectrum.

Isoaspartyl rearrangement

Aspartimide formation can reopen to place the chain through the aspartate side-chain carboxyl rather than the backbone one. Same atoms, different connectivity, identical mass. It is the most common such error in aspartate-containing peptides and it is sequence-dependent, so susceptibility can be predicted from the sequence even though the product cannot be seen by mass.

Research material referenced

BPC-157 5mg, third-party HPLC tested

Buy BPC-157 · £16.95

D-amino acid epimers

Racemisation during synthesis converts an L residue to its D form. A mirror image has identical mass and identical formula. No analytical mass difference exists to detect. This cuts both ways: MT-2 contains a deliberate D-phenylalanine, and mass spectrometry equally cannot confirm that it is present as specified. A sequence written without stereochemistry is not a complete specification.

Misfolded disulfide isomers

A protein with three disulfide bonds has six cysteines that can pair fifteen ways, of which one is correct. Every incorrect pairing has the same mass as the right one. IGF-1 LR3 is exactly this case, and it is why a certificate reporting mass and purity for a recombinant disulfide-containing protein has not addressed whether the molecule is folded correctly.

What does catch them

Chromatography, sometimes. These variants can differ in retention even at identical mass, which is why an unexplained shoulder on a peak deserves attention. Chiral analysis for stereochemistry. Activity assays for conformation, since a misfolded protein does not work. Each requires a method beyond the two that certificates usually carry.

The general point worth carrying

Mass confirms a molecule has the expected composition. It does not confirm the atoms are arranged as intended. Most peptide documentation answers composition twice (purity by HPLC and mass by MS) and never addresses arrangement at all, which is the gap these three impurity classes occupy.

Quick reference

ImpurityWhat changedDetected by
Isoaspartyl peptideBond positionChromatography, specific assays
D-amino acid epimerStereochemistryChiral analysis
Disulfide isomerCysteine pairingActivity, conformational methods
Deletion sequenceA residue missingMass spectrometry (this one is visible)

Frequently asked questions

Why can't mass spectrometry detect these?

It measures mass, from which formula follows. All three have the identical formula. Atoms were rearranged, not added or removed.

Does a clean mass spectrum mean a peptide is correct?

It means the composition is as expected. It says nothing about whether the atoms are arranged as intended.

What detects them instead?

Chromatography sometimes, chiral analysis for stereochemistry, and activity assays for conformation.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More Peptide Reference articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.